keyword
https://read.qxmd.com/read/37953264/differential-usage-of-dna-modifications-in-neurons-astrocytes-and-microglia
#1
JOURNAL ARTICLE
Kyla B Tooley, Ana J Chucair-Elliott, Sarah R Ocañas, Adeline H Machalinski, Kevin D Pham, Walker Hoolehan, Adam M Kulpa, David R Stanford, Willard M Freeman
BACKGROUND: Cellular identity is determined partly by cell type-specific epigenomic profiles that regulate gene expression. In neuroscience, there is a pressing need to isolate and characterize the epigenomes of specific CNS cell types in health and disease. In this study, we developed an in vivo tagging mouse model (Camk2a-NuTRAP) for paired isolation of neuronal DNA and RNA without cell sorting and then used this model to assess epigenomic regulation, DNA modifications in particular, of gene expression between neurons and glia...
November 13, 2023: Epigenetics & Chromatin
https://read.qxmd.com/read/37587511/microglial-senescence-contributes-to-female-biased-neuroinflammation-in-the-aging-mouse-hippocampus-implications-for-alzheimer-s-disease
#2
JOURNAL ARTICLE
Sarah R Ocañas, Kevin D Pham, Jillian E J Cox, Alex W Keck, Sunghwan Ko, Felix A Ampadu, Hunter L Porter, Victor A Ansere, Adam Kulpa, Collyn M Kellogg, Adeline H Machalinski, Manu A Thomas, Zsabre Wright, Ana J Chucair-Elliott, Willard M Freeman
BACKGROUND: Microglia, the brain's principal immune cells, have been implicated in the pathogenesis of Alzheimer's disease (AD), a condition shown to affect more females than males. Although sex differences in microglial function and transcriptomic programming have been described across development and in disease models of AD, no studies have comprehensively identified the sex divergences that emerge in the aging mouse hippocampus. Further, existing models of AD generally develop pathology (amyloid plaques and tau tangles) early in life and fail to recapitulate the aged brain environment associated with late-onset AD...
August 16, 2023: Journal of Neuroinflammation
https://read.qxmd.com/read/36674903/neuronal-dot1l-activity-acts-as-a-mitochondrial-gene-repressor-associated-with-human-brain-aging-via-h3k79-hypermethylation
#3
JOURNAL ARTICLE
Hendrikus J Van Heesbeen, Lars Von Oerthel, Paul M De Vries, Cindy M R J Wagemans, Marten P Smidt
Methylation of histone 3 at lysine 79 (H3K79) and its catalyst, a disrupter of telomeric silencing (DOT1l), have been coupled to multiple forms of stress, such as bioenergetic and ER challenges. However, studies on H3K79 methylation and Dot1l in the (aging) brain and neurons are limited. This, together with the increasing evidence of a dynamic neuroepigenome, made us wonder if H3K79 methylation and its activator Dot1l could play important roles in brain aging and associated disorders. In aged humans, we found strong and consistent global hypermethylation of H3K79 in neurons...
January 10, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36555213/targeted-methylation-profiling-of-single-laser-capture-microdissected-post-mortem-brain-cells-by-adapted-limiting-dilution-bisulfite-pyrosequencing-ldbsp
#4
JOURNAL ARTICLE
Renzo J M Riemens, Gunter Kenis, Jennifer Nolz, Sonia C Susano Chaves, Diane Duroux, Ehsan Pishva, Diego Mastroeni, Kristel Van Steen, Thomas Haaf, Daniël L A van den Hove
A reoccurring issue in neuroepigenomic studies, especially in the context of neurodegenerative disease, is the use of (heterogeneous) bulk tissue, which generates noise during epigenetic profiling. A workable solution to this issue is to quantify epigenetic patterns in individually isolated neuronal cells using laser capture microdissection (LCM). For this purpose, we established a novel approach for targeted DNA methylation profiling of individual genes that relies on a combination of LCM and limiting dilution bisulfite pyrosequencing (LDBSP)...
December 8, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/35750513/the-neuroepigenome-implications-of-chemical-and-physical-modifications-of-genomic-dna-in-schizophrenia
#5
REVIEW
Kiran Girdhar, Samir Rahman, Pengfei Dong, John F Fullard, Panos Roussos
Schizophrenia is a chronic mental illness with a substantial genetic component. To unfold the complex etiology of schizophrenia, it is important to understand the interplay between genetic and nongenetic factors. Genetic factors involve variation in the DNA sequences of protein-coding genes, which directly contribute to phenotypic traits, and variation in noncoding sequences, which comprise 98% of the genome and contain DNA elements known to play a role in regulating gene expression. The epigenome refers to the chemical modifications on both DNA and the structural proteins that package DNA into the nucleus, which together regulate gene expression in specific cell types, conditions, and developmental stages...
September 15, 2022: Biological Psychiatry
https://read.qxmd.com/read/34553604/understanding-environmental-epigenomics-in-autism-spectrum-disorder-an-interview-with-farah-r-zahir
#6
JOURNAL ARTICLE
Farah R Zahir
In this interview, Dr Farah R Zahir speaks with Storm Johnson, Commissioning Editor for Epigenomics , on her work to date in the field of epigenomics, autism and intellectual disability. Dr Farah R Zahir specializes in the identification of novel genetic and epigenetic causes for neurodevelopmental diseases. Her PhD, awarded in 2011 by the University of British Columbia (UBC), resulted in the characterization of new intellectual disability (ID) syndromes, as well as discovery of several new causative genes for the disorder...
September 23, 2021: Epigenomics
https://read.qxmd.com/read/34269202/exploring-the-alzheimer-s-disease-neuroepigenome-recent-advances-and-future-trends
#7
JOURNAL ARTICLE
Haolin Zhang, Felice Elefant
No abstract text is available yet for this article.
February 2022: Neural Regeneration Research
https://read.qxmd.com/read/34079067/key-transcription-factors-mediating-cocaine-induced-plasticity-in-the-nucleus-accumbens
#8
REVIEW
Collin D Teague, Eric J Nestler
Repeated cocaine use induces coordinated changes in gene expression that drive plasticity in the nucleus accumbens (NAc), an important component of the brain's reward circuitry, and promote the development of maladaptive, addiction-like behaviors. Studies on the molecular basis of cocaine action identify transcription factors, a class of proteins that bind to specific DNA sequences and regulate transcription, as critical mediators of this cocaine-induced plasticity. Early methods to identify and study transcription factors involved in addiction pathophysiology primarily relied on quantifying the expression of candidate genes in bulk brain tissue after chronic cocaine treatment, as well as conventional overexpression and knockdown techniques...
June 2, 2021: Molecular Psychiatry
https://read.qxmd.com/read/33901611/early-acoustic-experience-alters-genome-wide-methylation-in-the-auditory-forebrain-of-songbird-embryos
#9
JOURNAL ARTICLE
N D Antonson, M Rivera, M Abolins-Abols, S Kleindorfer, W-C Liu, M E Hauber
Early exposure to salient cues can critically shape the development of social behaviors. For example, both oscine birds and humans can hear and learn to recognize familiar sounds in ovo and in utero and recognize them following hatching and birth, respectively. Here we demonstrate that different chronic acoustic playbacks alter genome-wide methylation of the auditory forebrain in late-stage zebra finch (Taeniopygia guttata) embryos. Within the same subjects, immediate early gene activation in response to acute con- or heterospecific song exposure is negatively correlated with methylation extent in response to repeated daily prior exposure to the same type of stimuli...
April 24, 2021: Neuroscience Letters
https://read.qxmd.com/read/32704051/in-vivo-locus-specific-editing-of-the-neuroepigenome
#10
REVIEW
Yun Young Yim, Collin D Teague, Eric J Nestler
Studies over the past several decades have identified numerous epigenetic mechanisms associated with pathological states in psychiatric and neurological disease. Until recently, studies investigating chromatin-regulatory proteins, using overexpression or knockdown approaches, did not establish causal roles for epigenetic modifications at specific genes because these techniques typically affect hundreds or thousands of genomic loci. In this Review, we describe recent efforts in using locus-specific neuroepigenome editing in vivo to, for the first time, define causal relationships between a single chromatin modification at a specific gene in a defined cell population and downstream measures at the molecular, cellular, circuit and behavioural levels...
September 2020: Nature Reviews. Neuroscience
https://read.qxmd.com/read/29524136/viral-expression-of-epigenome-editing-tools-in-rodent-brain-using-stereotaxic-surgery-techniques
#11
JOURNAL ARTICLE
Peter J Hamilton, Carissa J Lim, Eric J Nestler, Elizabeth A Heller
Delivery of molecular tools for targeted epigenome editing in rodent brain can be facilitated by the use of viral vector-mediated gene transfer coupled with stereotaxic surgery techniques. Here, we describe the surgical protocol utilized by our group, which is optimized for herpes simplex virus (HSV)-mediated delivery into mouse brain. The protocol outlined herein could also be applied for delivery of adeno-associated viruses (AAV) or lentiviruses in both mice and rats. This method allows for efficient viral transgene expression and subsequent epigenome editing in rodent brain with excellent spatiotemporal control...
2018: Methods in Molecular Biology
https://read.qxmd.com/read/28387726/rethinking-the-epigenetic-framework-to-unravel-the-molecular-pathology-of-schizophrenia
#12
REVIEW
Ariel Cariaga-Martinez, Raúl Alelú-Paz
Schizophrenia is a complex mental disorder whose causes are still far from being known. Although researchers have focused on genetic or environmental contributions to the disease, we still lack a scientific framework that joins molecular and clinical findings. Epigenetic can explain how environmental variables may affect gene expression without modifying the DNA sequence. In fact, neuroepigenomics represents an effort to unify the research available on the molecular pathology of mental diseases, which has been carried out through several approaches ranging from interrogating single DNA methylation events and hydroxymethylation patterns, to epigenome-wide association studies, as well as studying post-translational modifications of histones, or nucleosomal positioning...
April 7, 2017: International Journal of Molecular Sciences
https://read.qxmd.com/read/26827128/understanding-the-genetic-liability-to-schizophrenia-through-the-neuroepigenome
#13
REVIEW
John F Fullard, Tobias B Halene, Claudia Giambartolomei, Vahram Haroutunian, Schahram Akbarian, Panos Roussos
The Psychiatric Genomics Consortium-Schizophrenia Workgroup (PGC-SCZ) recently identified 108 loci associated with increased risk for schizophrenia (SCZ). The vast majority of these variants reside within non-coding sequences of the genome and are predicted to exert their effects by affecting the mechanism of action of cis regulatory elements (CREs), such as promoters and enhancers. Although a number of large-scale collaborative efforts (e.g. ENCODE) have achieved a comprehensive mapping of CREs in human cell lines or tissue homogenates, it is becoming increasingly evident that many risk-associated variants are enriched for expression Quantitative Trait Loci (eQTLs) and CREs in specific tissues or cells...
November 2016: Schizophrenia Research
https://read.qxmd.com/read/25722961/neuroepigenomics-resources-obstacles-and-opportunities
#14
JOURNAL ARTICLE
John S Satterlee, Andrea Beckel-Mitchener, Roger Little, Dena Procaccini, Joni L Rutter, Amy C Lossie
Long-lived post-mitotic cells, such as the majority of human neurons, must respond effectively to ongoing changes in neuronal stimulation or microenvironmental cues through transcriptional and epigenomic regulation of gene expression. The role of epigenomic regulation in neuronal function is of fundamental interest to the neuroscience community, as these types of studies have transformed our understanding of gene regulation in post-mitotic cells. This perspective article highlights many of the resources available to researchers interested in neuroepigenomic investigations and discusses some of the current obstacles and opportunities in neuroepigenomics...
January 1, 2015: Neuroepigenetics
https://read.qxmd.com/read/25349914/analytical-tools-and-current-challenges-in-the-modern-era-of-neuroepigenomics
#15
REVIEW
Ian Maze, Li Shen, Bin Zhang, Benjamin A Garcia, Ningyi Shao, Amanda Mitchell, HaoSheng Sun, Schahram Akbarian, C David Allis, Eric J Nestler
Over the past decade, rapid advances in epigenomics research have extensively characterized critical roles for chromatin regulatory events during normal periods of eukaryotic cell development and plasticity, as well as part of aberrant processes implicated in human disease. Application of such approaches to studies of the CNS, however, is more recent. Here we provide a comprehensive overview of available tools for analyzing neuroepigenomics data, as well as a discussion of pending challenges specific to the field of neuroscience...
November 2014: Nature Neuroscience
https://read.qxmd.com/read/23888953/novel-therapeutic-targets-in-neuropsychiatric-disorders-the-neuroepigenome
#16
REVIEW
Lucio Tremolizzo, Virginia Rodriguez-Menendez, Elisa Conti, Chiara Paola Zoia, Guido Cavaletti, Carlo Ferrarese
The neuroepigenome, i.e., the epigenome of the nervous system, has become interesting for therapeutics in the last years due to widespread availability of dedicated drugs. A pivotal role for neuroepigenetics is certainly implied, both in physiology and pathology, by the highly dynamic structural and functional rearrangements that constantly occur into the nervous system, globally known as plasticity. Moreover, the idea that the pathophysiology of several neuropsychiatric disorders might involve epigenetic mechanisms is increasingly taking place due to accumulating experimental data and by the evidence of a synergistic interaction between genes and environment beneath most sporadic forms of these diseases...
2014: Current Pharmaceutical Design
https://read.qxmd.com/read/22122636/the-einstein-center-for-epigenomics-studying-the-role-of-epigenomic-dysregulation-in-human-disease
#17
JOURNAL ARTICLE
Andrew S McLellan, Robert A Dubin, Qiang Jing, Shahina B Maqbool, Raul Olea, Gael Westby, Pilib Ó Broin, Melissa J Fazzari, Deyou Zheng, Masako Suzuki, John M Greally
There is increasing interest in the role of epigenetic and transcriptional dysregulation in the pathogenesis of a range of human diseases, not just in the best-studied example of cancer. It is, however, quite difficult for an individual investigator to perform these studies, as they involve genome-wide molecular assays combined with sophisticated computational analytical approaches of very large datasets that may be generated from various resources and technologies. In 2008, the Albert Einstein College of Medicine in New York, USA established a Center for Epigenomics to facilitate the research programs of its investigators, providing shared resources for genome-wide assays and for data analysis...
October 2009: Epigenomics
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.